296 related articles for article (PubMed ID: 28648300)
21. Acute effects of the heavy metal antidotes DMPS and DMSA on circulation, respiration, and blood homoeostasis in dogs.
Klimmek R; Krettek C; Werner HW
Arch Toxicol; 1993; 67(6):428-34. PubMed ID: 8215913
[TBL] [Abstract][Full Text] [Related]
22. Efforts to control the errant products of a targeted in vivo generator.
Jaggi JS; Kappel BJ; McDevitt MR; Sgouros G; Flombaum CD; Cabassa C; Scheinberg DA
Cancer Res; 2005 Jun; 65(11):4888-95. PubMed ID: 15930310
[TBL] [Abstract][Full Text] [Related]
23. MRP2 and the DMPS- and DMSA-mediated elimination of mercury in TR(-) and control rats exposed to thiol S-conjugates of inorganic mercury.
Bridges CC; Joshee L; Zalups RK
Toxicol Sci; 2008 Sep; 105(1):211-20. PubMed ID: 18511429
[TBL] [Abstract][Full Text] [Related]
24. Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity.
Nakamura T; Yonezawa A; Hashimoto S; Katsura T; Inui K
Biochem Pharmacol; 2010 Dec; 80(11):1762-7. PubMed ID: 20813096
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
Juresa D; Blanusa M; Kostial K
Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
[TBL] [Abstract][Full Text] [Related]
26. Effects of some thiol chelators on enzymatic activities in blood, liver and kidneys of acute arsenic (III) exposed mice.
Tripathi N; Flora SJ
Biomed Environ Sci; 1998 Mar; 11(1):38-45. PubMed ID: 9559101
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic potential of meso 2,3-dimercaptosuccinic acid or 2,3-dimercaptopropane 1-sulfonate in chronic arsenic intoxication in rats.
Flora SJ; Dube SN; Arora U; Kannan GM; Shukla MK; Malhotra PR
Biometals; 1995 Apr; 8(2):111-6. PubMed ID: 7734923
[TBL] [Abstract][Full Text] [Related]
28. Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2.
Tanihara Y; Masuda S; Katsura T; Inui K
Biochem Pharmacol; 2009 Nov; 78(9):1263-71. PubMed ID: 19540211
[TBL] [Abstract][Full Text] [Related]
29. PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2.
Freitas-Lima LC; Budu A; Arruda AC; Perilhão MS; Barrera-Chimal J; Araujo RC; Estrela GR
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049997
[TBL] [Abstract][Full Text] [Related]
30. Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.
Ciarimboli G; Deuster D; Knief A; Sperling M; Holtkamp M; Edemir B; Pavenstädt H; Lanvers-Kaminsky C; am Zehnhoff-Dinnesen A; Schinkel AH; Koepsell H; Jürgens H; Schlatter E
Am J Pathol; 2010 Mar; 176(3):1169-80. PubMed ID: 20110413
[TBL] [Abstract][Full Text] [Related]
31. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
Zhang JS; Imai T; Otagiri M
Arch Toxicol; 2000 Aug; 74(6):300-7. PubMed ID: 11005675
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy.
Jones SB; Tiffany LJ; Garmestani K; Gansow OA; Kozak RW
Nucl Med Biol; 1996 Feb; 23(2):105-13. PubMed ID: 8868281
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of combined chelation in lead intoxication.
Tandon SK; Singh S; Jain VK
Chem Res Toxicol; 1994; 7(5):585-9. PubMed ID: 7841335
[TBL] [Abstract][Full Text] [Related]
34. Protection effects of Taurine supplementation against cisplatin-induced nephrotoxicity in rats.
Saad SY; Al-Rikabi AC
Chemotherapy; 2002 Mar; 48(1):42-8. PubMed ID: 11901256
[TBL] [Abstract][Full Text] [Related]
35. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity.
Yokoo S; Yonezawa A; Masuda S; Fukatsu A; Katsura T; Inui K
Biochem Pharmacol; 2007 Aug; 74(3):477-87. PubMed ID: 17582384
[TBL] [Abstract][Full Text] [Related]
36. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
Hanada K; Odaka K; Kudo A; Ogata H
Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
[TBL] [Abstract][Full Text] [Related]
37. Are we ready to replace dimercaprol (BAL) as an arsenic antidote?
Mückter H; Liebl B; Reichl FX; Hunder G; Walther U; Fichtl B
Hum Exp Toxicol; 1997 Aug; 16(8):460-5. PubMed ID: 9292286
[TBL] [Abstract][Full Text] [Related]
38. L-tetrahydropalmatine attenuates cisplatin-induced nephrotoxicity via selective inhibition of organic cation transporter 2 without impairing its antitumor efficacy.
Li C; Li L; Yi Y; Wang W; Yuan J; Tan F; Fang D; Zeng S; Zhou H; Jiang H
Biochem Pharmacol; 2020 Jul; 177():114021. PubMed ID: 32389634
[TBL] [Abstract][Full Text] [Related]
39. Effect of DMPS and DMSA on the placental and fetal disposition of methylmercury.
Bridges CC; Joshee L; Zalups RK
Placenta; 2009 Sep; 30(9):800-5. PubMed ID: 19615742
[TBL] [Abstract][Full Text] [Related]
40. Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin.
Hucke A; Schröter R; Ceresa C; Chiorazzi A; Canta A; Semperboni S; Marmiroli P; Cavaletti G; Gess B; Ciarimboli G
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
